Short interest in Vertex Pharmaceuticals jumped 27.5% in May, hitting 4.82 million shares—just under 2% of the float. This ...

The Biotechnology Market is projected to reach a multimillion-dollar valuation by 2034, driven by an unexpected compound annual growth rate (9.18) from 2025 to 2034.

On the occasion of World Multiple Sclerosis Day, Ad Scientiam announced that MSCopilot ®, its class IIa Software as a Medical Device (SaMD) dedicated to the monitoring of people living with multiple ...